OncoBreak: Economic Crisis and Cancer; Red Tape and Meds
MedPage Today,
savesaved Fallout from the 2008 global economic crisis contributed directly or indirectly to an additional 260,000 cancer…
No Clinical Benefit to Expanding Gene Panel Beyond Ovarian and Breast Cancer Genes in High-risk Women
Oncology Nurse Advisor ,
May 20, 2016 Expanding a panel of tested genes beyond the known breast and ovarian cancer-specific genes in patients with…
Testing Non-Breast/Ovarian Cancer Genes in High-Risk Women Leaves More Questions than Answers, Study Finds - Technology Org
Technology.org,
Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price of the technology…
Expanding gene panel beyond known breast/ovarian cancer genes does not add any clinical benefit
The Medical News,
Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price of the technology…
Families at Risk for Breast Cancer Gain Little Benefit, More Uncertainty From Expanded Gene Panel
Genomeweb,
NEW YORK (GenomeWeb) – Individuals suspected of being at increased risk for breast or ovarian cancer gain little clinically…
Testing non-breast cancer genes in high-risk women leaves more questions than answers: Expanding gene panel beyond breast/ovarian cancer genes did not add clinical benefit
Science Daily,
Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price of the technology…
Testing non-breast cancer genes in high-risk women leaves more questions than answers
MedicalXpress,
Mammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public Domain Running large, multi-gene…
Testing non-breast cancer genes in high-risk women leaves more questions than answers. ecancer
ecancer,
Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price of the technology…
Testing non-breast cancer genes in high-risk women leaves more questions than answers
EurekAlert!,
PHILADELPHI A-- Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price…